Page last updated: 2024-10-22

ambroxol and Liver Diseases

ambroxol has been researched along with Liver Diseases in 1 studies

Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Liver Diseases: Pathological processes of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"The aim of the study is to examine the effect of Ambroxol on TNF-α and IL-1β released after liver ischemia-reperfusion injury."8.12Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats? ( Cetinel, S; Gultekin, C; Sayiner, S; Sehirli, AO, 2022)
"The aim of the study is to examine the effect of Ambroxol on TNF-α and IL-1β released after liver ischemia-reperfusion injury."4.12Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats? ( Cetinel, S; Gultekin, C; Sayiner, S; Sehirli, AO, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gultekin, C1
Sehirli, AO1
Cetinel, S1
Sayiner, S1

Other Studies

1 other study available for ambroxol and Liver Diseases

ArticleYear
Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats?
    Bratislavske lekarske listy, 2022, Volume: 123, Issue:5

    Topics: Ambroxol; Animals; Cytokines; Ischemia; Liver; Liver Diseases; Rats; Rats, Wistar; Reperfusion Injur

2022